The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise

Urologic Oncology: Seminars and Original Investigations

Volumn 22, Issue 4, 2004, Pages 358-361

  Andriole, Gerald L ^a   Reding, Douglas ^b   Hayes, Richard B ^c   Prorok, Philip C ^c   Gohagan, John K ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MARSHFIELD CLINIC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Biorepository; Cancer screening; Prevention

Indexed keywords

ADULT; AGED; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SCREENING; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DATA BASE; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS;

AGED; COLONIC NEOPLASMS; DATABASES, FACTUAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; MORTALITY; OVARIAN NEOPLASMS; PROSTATIC NEOPLASMS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 3343019398     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2004.04.013     Document Type: Conference Paper

References (4)

1. Gohagan J.K., Prorok P.C., Hayes R.B., Kramer B.S. PLCO Project Team. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute history, organization, and status. Controlled Clinical Trials. 21:2000;251S-272S
2. Hayes R.B., Reding D., Kopp W., et al. PLCO Project Team. Etiologic and early marker studies in the Prostate, Lung, Colorectal and Ovarian (OLCO) Cancer Screening Trial. Controlled Clinical Trials. 21:2000;349S-355S
3. Prorok P.C., Andriole G.L., Bresalier R.S., et al. PLCO Project Team. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Controlled Clinical Trials. 21:2000;273S-309S
4. Lum A., LeMarchand L. A simple mouthwash method for obtaining genomic DNA in molecular epidemiologic studies. Cancer Epidemiol Biomarkers Prev. 7:1998;719-724